ARCA biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ARCA biopharma and buy or sell other stocks, ETFs, and their options commission-free!About ABIO
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002.
CEOLawrence O. Klein, PhD
CEOLawrence O. Klein, PhD
Employees28
Employees28
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded
Founded
Employees28
Employees28
ABIO Key Statistics
Market cap119.44M
Market cap119.44M
Price-Earnings ratio-1.91
Price-Earnings ratio-1.91
Dividend yield—
Dividend yield—
Average volume123.31K
Average volume123.31K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$33.00
52 Week high$33.00
52 Week low$5.49
52 Week low$5.49
Stock Snapshot
With a market cap of 119.44M, ARCA biopharma(ABIO) trades at $3.19. The stock has a price-to-earnings ratio of -1.91.
On 2025-11-23, ARCA biopharma(ABIO) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for ARCA biopharma(ABIO) stock has reached 0, versus its average volume of 123.31K.
Over the past 52 weeks, ARCA biopharma(ABIO) stock has traded between a high of $33.00 and a low of $5.49.
Over the past 52 weeks, ARCA biopharma(ABIO) stock has traded between a high of $33.00 and a low of $5.49.